This compound is a this compound derivative. It is primarily used as a pharmaceutical intermediate in the manufacturing of kinase inhibitors for research and development purposes.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1220518-04-6
Tert-Butyl 4-chloro-7H-pyrrolo[2,3-d]pyrimidine-7-carboxylate
Pharmaceutical intermediate for kinase inhibitors
1-(benzenesulfonyl)-4-chloro-5-nitro-1H-pyrrolo[2,3-b]pyridine
Pharmaceutical intermediate for kinase inhibitors
Tert-butyl 8-hydroxy-4-methylsulfanyl-10-oxo-spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-11-carboxylate
Pharmaceutical intermediate for kinase inhibitors
5-[4-[[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-furancarboxaldehyde
Pharmaceutical intermediate for kinase inhibitors
Acarbose Impurity E
Acarbose impurity reference standard
Acarbose EP Impurity B
Impurity standard for acarbose analysis
(2R,3R)-2-[(benzoyloxy)methyl]-4,4-difluoro-5-oxooxolan-3-yl benzoate
pharmaceutical intermediate
2-deoxy-2,2-difluoro-d-erythro-pentofuranose-3,5-dibenzoate-1-methanesulfonate
pharmaceutical intermediate for nucleoside analogs
2,4-dichloro-7-cyclopropylpyrrolo[2,3-d]pyrimidine
FWAVMANUFQKJFX-UHFFFAOYSA-N
C1CC1N2C=CC3=C2N=C(N=C3Cl)Cl
—